Naveen Pemmaraju: Amazing job speaking in the Fellows’ Roundtable at HOPLive24

Naveen Pemmaraju shared on LinkedIn:

“Shout out to our outstanding MD Anderson Cancer Center medical hematology/oncology fellow MDs Dr. Hannah Goulart and Dr. Hima Atluri, who joined me at the HemOnc Pulse Live 2024 meeting in Chicago, for an amazing job they did speaking in the Fellows’ Roundtable at HOPLive24 meeting organized by Chadi Nabhan and team earlier this month!”

Source: Naveen Pemmaraju/LinkedIn

Naveen Pemmaraju is a Professor and Director of BPDCN Program at the Department of Leukemia at the University of Texas MD Anderson Cancer Center (MDACC) and Executive Director of MDACC Network. He is also the Leukemia Hematology/Oncology Course Director.

His research work has been focused on improving outcomes and developing novel therapies for patients with rare, and ultra-rare, myeloid malignancies; including adolescents, young adults, and older adult patients with Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN), MPN and AML.

He has been named MDACC’s, Department of Leukemia, Inaugural Director of BPDCN Program, in 2020, which is one of the world’s most active BPDCN research programs. Dr. Pemmaraju is the recipient of the MDACC Gerald P. Bodey Award for Excellence in Education in 2020. He is a well-known social media influencer and advocate.